Cargando…

Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy

Immune-targeted approaches are rapidly changing the therapeutic landscape for cancer. In spite of that, most patients show resistance or acquire resistance to these therapies. Increasing work describing the tumor microenvironment (TME) has highlighted this space as one of the key determinants in tum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barrett, Richard, Puré, Ellen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228400/ https://www.ncbi.nlm.nih.gov/pubmed/32402828 http://dx.doi.org/10.1016/j.coi.2020.03.004

Ejemplares similares

Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy
por: Barrett, Richard Lee, et al.
Publicado: (2020)

Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics
por: Puré, Ellen, et al.
Publicado: (2018)

Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intra-tumoral stromagenesis
por: Cho, Christina, et al.
Publicado: (2020)

Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles
por: Tchou, Julia, et al.
Publicado: (2012)

Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy
por: Raskov, Hans, et al.
Publicado: (2021)

Cancer-Associated Fibroblasts Are Key Determinants of Cancer Cell Invasion in the Earliest Stage of Colorectal Cancer
por: Dang, Hao, et al.
Publicado: (2023)

Immune Determinants of the Association between Tumor Mutational Burden and Immunotherapy Response across Cancer Types
por: Sinha, Neelam, et al.
Publicado: (2022)

Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion
por: Hilmi, Marc, et al.
Publicado: (2020)

The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer
por: Stouten, Imke, et al.
Publicado: (2023)

TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure
por: Chakravarthy, Ankur, et al.
Publicado: (2018)

Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
por: Liu, Tongyan, et al.
Publicado: (2019)

Editorial: Crosstalk between cancer-associated fibroblasts and tumor cells in the tumor microenvironment: an emerging target of anti-cancer immunotherapy
por: Zhang, Chunxue, et al.
Publicado: (2023)

Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer
por: Shinkawa, Tomohiko, et al.
Publicado: (2022)

Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy
por: Vienot, Angélique, et al.
Publicado: (2022)

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
por: Payne, Kyle K., et al.
Publicado: (2012)

The Communication from Immune Cells to the Fibroblasts in Keloids: Implications for Immunotherapy
por: Zhang, Xiya, et al.
Publicado: (2023)

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
por: Zhang, Hao, et al.
Publicado: (2023)

Immune gene patterns and characterization of the tumor immune microenvironment associated with cancer immunotherapy efficacy
por: Lin, Lili, et al.
Publicado: (2023)

Tumor immune response and immunotherapy in gastric cancer
por: Kwak, Yoonjin, et al.
Publicado: (2020)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

Myeloid-derived cells are key targets of tumor immunotherapy
por: Medina-Echeverz, José, et al.
Publicado: (2014)

Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy
por: Feng, Hai, et al.
Publicado: (2022)

Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies
por: Mortara, Lorenzo, et al.
Publicado: (2022)

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
por: Xu, Shumin, et al.
Publicado: (2023)

Immune mechanisms in vulvodynia: key roles for mast cells and fibroblasts
por: Tonc, Elena, et al.
Publicado: (2023)

Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors
por: Rivas, Elisa I., et al.
Publicado: (2022)

Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer
por: Soongsathitanon, Jarupa, et al.
Publicado: (2021)

Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma
por: Wong, Pok Fai, et al.
Publicado: (2019)

A framework for advancing our understanding of cancer-associated fibroblasts
por: Sahai, Erik, et al.
Publicado: (2020)

Z-DNA enhances immunotherapy by triggering death of inflammatory cancer-associated fibroblasts
por: Herbert, Alan, et al.
Publicado: (2022)

Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts
por: Rodriguez, Anthony B., et al.
Publicado: (2021)

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
por: Devaud, Christel, et al.
Publicado: (2013)

The immune landscape of human tumors: Implications for cancer immunotherapy
por: Bindea, Gabriela, et al.
Publicado: (2014)

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
por: Li, Bo, et al.
Publicado: (2016)

Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade
por: Miyai, Yuki, et al.
Publicado: (2022)

Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance
por: Ireland, Lucy V., et al.
Publicado: (2018)

The effects of MYC on tumor immunity and immunotherapy
por: Li, Jiajin, et al.
Publicado: (2023)

Role of the tumor immune microenvironment in tumor immunotherapy
por: Zhou, Changsheng, et al.
Publicado: (2022)

Loss of p19Arf promotes fibroblast survival during leucine deprivation
por: Roby, Kerry C., et al.
Publicado: (2022)

Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives
por: Hanley, Christopher J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7lh3du0k1sopi33b4g8d2hu3bl